Skip to Main Content
Contribute Try STAT+ Today

In a wide-ranging and forthcoming interview, Eric Schmidt, the former Google CEO who helped steer the tech giant’s foray into health care, opened up about a host of issues facing the future of medicine.

Among the topics Schmidt touched on in a half-hour conversation at the STAT Health Tech Summit: his upcoming role as the board chair of the powerful Broad Institute, why synthetic biology is a critical field to watch, the fraught debate over patient data privacy and health systems, and why Boston should double down on investing in the life sciences.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.